Sabrina Paganoni

Neuromusculoskeletal Medicine

300 1st Ave
Charlestown, MA 02129

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 168 publications

Traumatic Brain Injury and Risk of Amyotrophic Lateral Sclerosis Mortality: A Traumatic Brain Injury Model Systems Study.

Traumatic Brain Injury and Risk of Amyotrophic Lateral Sclerosis Mortality: A Traumatic Brain Injury Model Systems Study.

Journal: Neurotrauma reports

Published: August 01, 2026

Antisense Oligonucleotide Tofersen Distribution in the Central Nervous System of SOD1-ALS Autopsy Tissue Donors.

Antisense Oligonucleotide Tofersen Distribution in the Central Nervous System of SOD1-ALS Autopsy Tissue Donors.

Journal: JAMA neurology

Published: July 06, 2026

The Case for Master Protocols for Rare Neurological Diseases.

The Case for Master Protocols for Rare Neurological Diseases.

Journal: Annals of neurology

Published: April 28, 2026

Bridging the gap: understanding participation barriers in ALS clinical trials through on-the-ground insights.

Bridging the gap: understanding participation barriers in ALS clinical trials through on-the-ground insights.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: March 05, 2026

ALSUntangled #82: N-acetylcysteine.

ALSUntangled #82: N-acetylcysteine.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: March 04, 2026

Reliability and construct validity of the Italian version of AMAT scale in SBMA subjects.

Reliability and construct validity of the Italian version of AMAT scale in SBMA subjects.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: February 26, 2026

Optimizing Research Operations and Resource Utilization in ALS Care: Insights From the Tofersen Antisense Oligonucleotide Expanded Access Protocol.

Optimizing Research Operations and Resource Utilization in ALS Care: Insights From the Tofersen Antisense Oligonucleotide Expanded Access Protocol.

Journal: Muscle & nerve

Published: February 12, 2026

Enabling Functional Independence: A Scoping Review of Upper Extremity Assistive Devices for Adults With Progressive Neuromuscular Diseases.

Enabling Functional Independence: A Scoping Review of Upper Extremity Assistive Devices for Adults With Progressive Neuromuscular Diseases.

Journal: Muscle & nerve

Published: January 12, 2026

Pridopidine treatment in ALS: subgroup analyses from the HEALEY ALS Platform trial.

Pridopidine treatment in ALS: subgroup analyses from the HEALEY ALS Platform trial.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: December 17, 2025

Phosphorylated Tau at Threonine 181 Is Elevated in Amyotrophic Lateral Sclerosis Plasma.

Phosphorylated Tau at Threonine 181 Is Elevated in Amyotrophic Lateral Sclerosis Plasma.

Journal: Muscle & nerve

Published: December 17, 2025

Utility of patient subgrouping in ALS clinical trials: a World Federation of Neurology white paper.

Utility of patient subgrouping in ALS clinical trials: a World Federation of Neurology white paper.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: December 09, 2025

The Use of Durable Medical Equipment in COURAGE-ALS, a Phase 3, Multicentre, Randomized Clinical Trial for ALS.

The Use of Durable Medical Equipment in COURAGE-ALS, a Phase 3, Multicentre, Randomized Clinical Trial for ALS.

Journal: Muscle & nerve

Published: October 29, 2025

Showing 1-12 of 168

Last Updated: 09/26/2026